Last reviewed · How we verify

NCT06969131

Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors

Completed NA Last updated 13 May 2025
What this trial tests

NA trial testing Open Partial Nephrectomy in Pentafecta in 70 participants. Completed in 1 May 2024.

Timeline
1 May 2022
Primary endpoint
1 May 2024
1 May 2024

Quick facts

Lead sponsorSouth Valley University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment70
Start date1 May 2022
Primary completion1 May 2024
Estimated completion1 May 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

South Valley University

Who can join

18 and older, any sex, with Pentafecta or Laparoscopic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to identify predictive factors associated with the achievement of pentafecta outcomes following partial nephrectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Open Partial Nephrectomy

Trials testing the same drug.

Other South Valley University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06969131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing